APA (7th ed.) Citation

Mutoh, Y., Umemura, T., Nishikawa, T., Kondo, K., Nishina, Y., Soejima, K., . . . Kimura, T. (2023). Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting. Viruses (1999-4915), 15(3), 811. https://doi.org/10.3390/v15030811

Chicago Style (17th ed.) Citation

Mutoh, Yoshikazu, et al. "Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting." Viruses (1999-4915) 15, no. 3 (2023): 811. https://doi.org/10.3390/v15030811.

MLA (9th ed.) Citation

Mutoh, Yoshikazu, et al. "Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting." Viruses (1999-4915), vol. 15, no. 3, 2023, p. 811, https://doi.org/10.3390/v15030811.